Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03408379

Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
230 (actual)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Sub arachnoid hemorrhage consecutive to intracranial aneurysm rupture is a devastating disease. Predictors of intracranial aneurysm rupture are limited and focus mainly on size and location. Platelet activation may have a deleterious role on aneurysm rupture. The assumption is that patients with ruptured intracranial aneurysm will present a higher rate of platelet activation compared to patients with non ruptured aneurysms.

Conditions

Interventions

TypeNameDescription
OTHERCollection of blood sample in aneurysmIn case of an endovascular treatment : * A blood sample (venous or arterial) of 10 ml will be taken at the beginning of the procedure, an intra aneurysmal blood sample (1mL) will be taken during the procedure and a blood sample (arterial) of 1 mL will be taken at the end of the procedure. * Iterative blood samples (arterial) of 10 mL will be taken at each follow up visit. In case of a surgery treatment : * A blood sample (venous or arterial) of 10 ml will be taken at the beginning of the surgery. * A Tissue sample will be taken during the surgery * Iterative blood samples (arterial) of 10 mL will be taken at each follow up visit.

Timeline

Start date
2017-12-20
Primary completion
2032-06-23
Completion
2033-06-23
First posted
2018-01-24
Last updated
2026-01-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03408379. Inclusion in this directory is not an endorsement.